No abstract available
MeSH terms
-
Antitubercular Agents / adverse effects*
-
Antitubercular Agents / therapeutic use
-
Dose-Response Relationship, Drug
-
Humans
-
Maximum Tolerated Dose
-
Proportional Hazards Models
-
Pyrazinamide / adverse effects*
-
Pyrazinamide / therapeutic use
-
Risk Assessment
-
Tuberculosis, Pulmonary / diagnosis
-
Tuberculosis, Pulmonary / drug therapy*
Substances
-
Antitubercular Agents
-
Pyrazinamide